These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8759709)

  • 1. Systemic levels of soluble CD44 variant 6 (sCD44v6) in chronic inflammatory bowel disease.
    Folwaczny C; Noehl N; Urban S; Loeschke K; Heldwein W; Jochum M; Fricke H
    Am J Gastroenterol; 1996 Aug; 91(8):1680-1. PubMed ID: 8759709
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers for inflammatory bowel disease.
    Foley KF; Kao P
    Clin Lab Sci; 2007; 20(2):84-8. PubMed ID: 17557707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crohn disease or hemorrhagic rectocolitis? CD 44V6 and CD 44V3 adhesion molecules can make the difference].
    Lémann M
    Gastroenterol Clin Biol; 1995; 19(8-9):741-2. PubMed ID: 8522134
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical consideration of the cytokines in inflammatory bowel disease.
    Dolar ME
    Am J Gastroenterol; 1995 Mar; 90(3):520-1. PubMed ID: 7872308
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
    Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
    Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory bowel disease in children and adolescents. When can the diagnosis be excluded without a referral to a pediatric gastroenterologist?].
    Bennet R
    Lakartidningen; 1999 Jan; 96(1-2):49-51. PubMed ID: 9951250
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
    Kull K; Salupere R; Uibo R; Ots M; Salupere V
    Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of platelet count as an activity index in chronic inflammatory intestinal diseases].
    Olm Font M; Guevara C; García-Pugés A; Navarro S
    Med Clin (Barc); 1988 Oct; 91(10):397. PubMed ID: 3216739
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
    Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
    Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease.
    Shah SA; Feller ER
    Med Health R I; 2009 Mar; 92(3):72. PubMed ID: 19385380
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological tests to monitor inflammatory bowel disease--have they delivered yet?
    Cronin CC; Shanahan F
    Am J Gastroenterol; 1998 Mar; 93(3):295-7. PubMed ID: 9517627
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microbial enterocolitis--its significance in the differential diagnosis and follow-up of chronic inflammatory bowel diseases].
    Lehn N; Bayerdörffer E
    Internist (Berl); 1991 Sep; 32(9):549-52. PubMed ID: 1660045
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic inflammatory bowel diseases. Dermatoses and joint pain can be the initial symptoms].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Apr; 145(17):14. PubMed ID: 12808794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.